For SOT, the first analyses in this regard were performed by Del Bello et al., revealing that the overall count of CD3+ and CD8+ T cells is significantly reduced in SOT (kidney, liver, heart, pancreas) with severe COVID-19 [145]. This evidence concerns the gene CD8A and COVID-19.